Simple test could predict response to anthracycline chemotherapy for patients with 'triple negative' breast cancer

Could this be a turning point in breast cancer research?

Researchers at Queen’s University Belfast have found a new biomarker that could predict the effectiveness of a common type of chemotherapy for patients with triple negative breast cancer. To read more about this exciting discovery, click the link below:

Share This Article

Breast Cancer Ireland

Lower Ground Floor
Breast Cancer Ireland
77 Merrion Square South
Dublin 2

Tel: 00353-1-5160331

Charity No: Chy 19926

Breast Cancer Ireland has been incorporated as Breast Cancer Ireland CLG, trading as: Breast Cancer Ireland